Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5Gy-Reference-Cited by-同舟云学术

Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5Gy

Published:2017-01 Issue:1 Volume:122 Page:87-92
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Morton Gerard,Chung Hans T.,McGuffin Merrylee,Helou Joelle,D’Alimonte Laura,Ravi Ananth,Cheung Patrick,Szumacher Ewa,Liu Stanley,Al-Hanaqta Motasem,Zhang Liying,Mamedov Alexandre,Loblaw Andrew

Funder

Canadian Association of Radiation Oncologists

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference16 articles.

1. High-dose-rate brachytherapy boost for prostate cancer: rationale and technique;Morton;J Contemp Brachytherapy,2014

2. High-dose-rate brachytherapy as monotherapy for prostate cancer;Demanes;Brachytherapy,2014

3. Prostate Cancer, Version 1.2016;Mohler;J Natl Compr Canc Netw,2016

4. High-dose-rate interstitial brachytherapy as monotherapy in one fraction and transperineal hyaluronic acid injection into the perirectal fat for the treatment of favorable stage prostate cancer: treatment description and preliminary results;Prada;Brachytherapy,2012

5. High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: acute toxicity;Hoskin;Radiother Oncol,2014

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate high dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy: A 9-year update;Radiotherapy and Oncology;2024-09

2. Stereotactic Body Radiotherapy (SBRT) to Localised Prostate Cancer in the Era of MRI-Guided Adaptive Radiotherapy: Doses Delivered in the HERMES Trial Comparing Two- and Five-Fraction Treatments;Cancers;2024-05-30

3. ONE SHOT - single shot radiotherapy for localized prostate cancer: 18-month results of a single arm, multicenter phase I/II trial;Radiotherapy and Oncology;2024-05

4. Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial;Clinical and Translational Radiation Oncology;2023-05

5. Safety and efficacy associated with single-fraction high-dose-rate brachytherapy in localized prostate cancer: a systematic review and meta-analysis;Strahlentherapie und Onkologie;2023-04-24